Biocartis Group Nv Stock EBITDA
| BCART Stock | EUR 0.29 0.00 0.00% |
Biocartis Group NV fundamentals help investors to digest information that contributes to Biocartis Group's financial success or failures. It also enables traders to predict the movement of Biocartis Stock. The fundamental analysis module provides a way to measure Biocartis Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biocartis Group stock.
Biocartis |
Biocartis Group NV Company EBITDA Analysis
Biocartis Group's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Biocartis Group EBITDA | (52.55 M) |
Most of Biocartis Group's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biocartis Group NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Biocartis Group NV reported earnings before interest,tax, depreciation and amortization of (52.55 Million). This is 105.99% lower than that of the Health Care Equipment & Supplies sector and 115.15% lower than that of the Health Care industry. The ebitda for all Belgium stocks is 101.35% higher than that of the company.
Biocartis EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biocartis Group's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biocartis Group could also be used in its relative valuation, which is a method of valuing Biocartis Group by comparing valuation metrics of similar companies.Biocartis Group is currently under evaluation in ebitda category among its peers.
Biocartis Fundamentals
| Return On Equity | -48.84 | |||
| Return On Asset | -0.22 | |||
| Profit Margin | (1.07) % | |||
| Operating Margin | (0.85) % | |||
| Current Valuation | 182.31 M | |||
| Shares Outstanding | 93.1 M | |||
| Shares Owned By Insiders | 6.66 % | |||
| Shares Owned By Institutions | 27.71 % | |||
| Price To Earning | (9.91) X | |||
| Price To Book | 6.47 X | |||
| Price To Sales | 0.89 X | |||
| Revenue | 48.27 M | |||
| Gross Profit | (25.72 M) | |||
| EBITDA | (52.55 M) | |||
| Net Income | (71.47 M) | |||
| Cash And Equivalents | 53.52 M | |||
| Cash Per Share | 0.93 X | |||
| Total Debt | 128.15 M | |||
| Debt To Equity | 40.40 % | |||
| Current Ratio | 2.82 X | |||
| Book Value Per Share | (1.07) X | |||
| Cash Flow From Operations | (65.72 M) | |||
| Earnings Per Share | (1.24) X | |||
| Target Price | 1.8 | |||
| Number Of Employees | 619 | |||
| Beta | 1.51 | |||
| Market Capitalization | 60.8 M | |||
| Total Asset | 142.48 M | |||
| Retained Earnings | (188 M) | |||
| Working Capital | 90 M | |||
| Current Asset | 118 M | |||
| Current Liabilities | 28 M | |||
| Z Score | -1.4 | |||
| Net Asset | 142.48 M |
About Biocartis Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biocartis Group NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biocartis Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biocartis Group NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in Biocartis Stock
Biocartis Group financial ratios help investors to determine whether Biocartis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biocartis with respect to the benefits of owning Biocartis Group security.